WASHINGTON, Dec 11 (NNN-AGENCIES) — US experts voted Thursday to recommend granting emergency approval for Pfizer-BioNTech’s Covid-19 vaccine, paving the way for America to become the next country to move ahead with mass immunization.
It comes as the worst-hit country in the world logged more than 3,000 virus
deaths in one day and its overall toll was approaching 300,000.
With northern hemisphere countries hit by a pandemic winter surge, Britain this week became the first Western country to roll out the Pfizer-BioNTech vaccine.
Canada, Bahrain and Saudi Arabia have also approved it.
EU countries eagerly awaited a greenlight for vaccines that the bloc’s own
watchdog said remained on track for approval despite a two-week-long
cyberattack, which is under investigation.
Independent experts convened by the US Food and Drug Administration (FDA) voted 17 in favor, four against and with one abstention for emergency approval of the two-dose regimen in over-16s.
The vote is non-binding, but a formal emergency use authorization (EUA) is
expected within days.
Momentum was building as the New England Journal of Medicine published full results of a clinical trial of the vaccine involving nearly 44,000 people, which confirmed it was 95 percent effective with no serious safety issues.
“The trial results are impressive enough to hold up in any conceivable
analysis. This is a triumph,” an accompanying editorial said.
Nevertheless, the voting members of the Vaccines and Related Biological
Products Advisory Committee (VRBPAC) mulled outstanding issues closely in a live-streamed event held over the course of the day.
These included difficult questions like when people who got placebos in the
trial should receive the vaccine, a tricky debate that weighs the need for
more controlled data against paying back altruistic volunteers for their
service.
Other questions include whether unexpected safety issues may arise when the number of people vaccinated grows to millions and possibly billions of
people.
Also unknown is whether more side effects will emerge with longer follow-
up, how long the vaccine remains effective, whether it will limit
transmission and how it will work in children, pregnant women, and
immunocompromised patients.
The FDA said it would issue an allergy warning following Britain’s lead
after two health care workers there suffered reactions and needed treatment.
The virus has killed at least 1,570,398 people worldwide since the outbreak
emerged in China last December, according to official sources.
The US hopes to vaccinate 20 million people this month, with long-term care
facility residents and health workers at the front of the line.
